M. Grisanti

发表

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

P. Kostenuik, M. Stolina, H. Ke, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock‐In Mice That Express Chimeric (Murine/Human) RANKL

P. Kostenuik, S. Morony, W. Dougall, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.

P. Kostenuik, M. Stolina, H. Ke, 2009, Bone.

Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.

P. Kostenuik, M. Stolina, H. Ke, 2014, Endocrinology.

Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.

P. Kostenuik, M. Stolina, H. Ke, 2014, Bone.

Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.

P. Kostenuik, M. Stolina, H. Ke, 2011, Endocrinology.

Effect of low dietary calcium on bone metabolism in the SENCAR mouse

M. Urist, S. Murray, M. Duarte, 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Infrequent Delivery of a Long‐Acting PTH‐Fc Fusion Protein Has Potent Anabolic Effects on Cortical and Cancellous Bone

Steven W. Martin, P. Kostenuik, S. Morony, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

RANKL Inhibition with Osteoprotegerin Increases Bone Strength by Improving Cortical and Trabecular bone Architecture in Ovariectomized Rats

P. Kostenuik, M. Stolina, H. Ke, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Characterization of osteoclast precursors in human blood

D. Lacey, N. Hawkins, M. Kelley, 2000, British journal of haematology.

The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells.

S. Murray, M. Grisanti, E. Murray, 1998, Experimental cell research.

Characterization of osteoclast precursors in human blood.

D. Lacey, N. Hawkins, M. Kelley, 2000 .

The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.

P. Kostenuik, S. Morony, C. Capparelli, 2005, Endocrinology.

The RANKL Inhibitor Osteoprotegerin (OPG) Causes Greater Suppression of Bone Resorption and Hypercalcemia Compared to Bisphosphonates in Two Models of Humoral Hypercalcemia of Malignancy

P. Kostenuik, S. Morony, C. Capparelli, 2005 .

E64d, a membrane-permeable cysteine protease inhibitor, attenuates the effects of parathyroid hormone on osteoblasts in vitro.

S. Murray, M. Grisanti, E. Murray, 1997, Metabolism: clinical and experimental.

Effects of dietary restriction on appendicular bone in the SENCAR mouse.

W. Beamer, S. Murray, K. Behnam, 2001, Metabolism: clinical and experimental.

Generalized Degenerative Joint Disease in Osteoprotegerin (Opg) Null Mutant Mice

S. Morony, B. Bolon, W. S. Simonet, 2015, Veterinary pathology.

One Year of Transgenic Overexpression of Osteoprotegerin in Rats Suppressed Bone Resorption and Increased Vertebral Bone Volume, Density, and Strength

P. Kostenuik, M. Stolina, H. Ke, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression

J. Zwerina, G. Schett, J. Distler, 2010, Annals of the rheumatic diseases.

The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells.

S. Murray, A. Kahn, M. Urist, 1997, Experimental cell research.

Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis

H. Ke, W. S. Simonet, T. Wronski, 2018, Endocrinology.

A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair

W. Richards, K. Gunasekaran, M. Stolina, 2016, Nature Communications.

Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism.

W. Richards, M. Stolina, J. Tomlinson, 2017, Bone.

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.

P. Kostenuik, S. Morony, D. Lacey, 2006, Bone.

Purification and quantification of calcium-activated neutral proteases I and II and novel isoforms from cultured osteoblastic cells by ion-exchange fast protein liquid chromatography.

S. Murray, K. Behnam, M. Grisanti, 2000, Methods in molecular biology.

New Variants in the Enpp1 and Ptpn6 Genes Cause Low BMD, Crystal‐Related Arthropathy, and Vascular Calcification

S. Morony, C. Ebeling, M. Roudier, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Dickkopf‐1 regulates bone formation in young growing rodents and upon traumatic injury

P. Kostenuik, D. Lacey, T. Horan, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

In vitro studies with the calcimimetic, cinacalcet HCl, on normal human adult osteoblastic and osteoclastic cells.

D. Lacey, V. Shalhoub, David A. Martin, 2003, Critical reviews in eukaryotic gene expression.

Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone

P. Kostenuik, M. Stolina, H. Ke, 2023, The Journal of bone and joint surgery. American volume.

Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.

P. Kostenuik, M. Stolina, H. Ke, 2011, Endocrinology.

Sclerostin Inhibition by Monoclonal Antibody Accelerates the Bone Healing Process in an Ovariectomized Rat Cortical Defect Model: An in vivo microCT Study

M. Toupikov, W. S. Simonet, K. Warmington, 2011 .